Skip to content

Clinical study of intermittent theta burst stimulation in the treatment of dysphagia after stroke

Clinical study of intermittent theta burst stimulation in the treatment of dysphagia after stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053896
Enrollment
Unknown
Registered
2021-12-02
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke dysphagia

Interventions

Group 1:theta burst magnetic stimulation
Group 2:repetitive transcranial stimulation

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of ''Key Points for Diagnosis of Various Cerebrovascular Diseases'' revised by the Fourth National Cerebrovascular Disease Academic Conference of the Chinese Medical Association and confirmed by CT or MRI, the diagnosis is ischemic or hemorrhagic stroke; 2. Water field drinking test >= grade 3, 2 weeks <= onset time <= 3 months; 3. The patient is conscious, his vital signs are stable, and he can actively cooperate with the treatment; 4. The blood pressure fluctuation range is small, and the blood pressure control is stable below 160/100mmHg; 5. Before entering the group, the consent of the patients and their families should be obtained, and the informed consent form for TBS treatment should be signed.

Exclusion criteria

Exclusion criteria: 1. Patients with brainstem stroke and swallowing dysfunction caused by non-stroke; 2. Patients with dysphagia caused by pathological changes of swallowing organs and brainstem injury; 3. After local neck lesions, foreign bodies or related surgical treatment, such as patients with thyroid disease, tracheotomy, etc., there are contraindications to magnetic stimulation, such as those with pacemakers and metal in the brain; 4. Unstable arrhythmia; 5. Patients with a history of epilepsy; 6. Patients with fever, infection or vital organ failure, and critically ill patients; 7. Those who cannot cooperate with the assessment or treatment due to cognitive dysfunction or emotional reasons.

Design outcomes

Primary

MeasureTime frame
standardized swallowing assessment;

Secondary

MeasureTime frame
the water-swallowing test;penetration-aspiration scale;modified Mann assessment of swallowing ability;

Countries

China

Contacts

Public ContactXie Yulei

Affiliated Hospital of North Sichuan Medical College

xieyulei123@foxmail.com+86 15181750395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026